The Company is a leading UK-based diagnostics company specialising in the development of next generation diagnostic platforms for use in decentralised and point-of-care settings. The company was founded in 2004 as a spin-off from the UK Ministry of Defence, based on an exclusively licensed intellectual property portfolio from the UK Defence Science Technology Laboratory. Enigma has a strategic alliance with a major multinational healthcare company to commercialise its diagnostic equipment on a global basis. The company has acquired all the regulatory approvals enabling it commercialize its product globally. Tadhamon Capital invested in Enigma in 2010.